This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Croize, J Articles by Colomb, M G Search for Related Content PubMed PubMed Citation Articles by Croize, J Articles by Colomb, M G

 Previous Article  |  Next Article 

Infect Immun. 1993 December; 61(12): 5134-5139

Activation of the human complement alternative pathway by Listeria monocytogenes: evidence for direct binding and proteolysis of the C3 component on bacteria.

Laboratoire d'immunochimie, DBMS/ICH, Institut National de la Santé et de la Recherche Médicale U. 238, Grenoble, France.

ABSTRACT

The capacity of the intracellular pathogen Listeria monocytogenes to activate the alternative pathway of human complement was examined. Incubation of L. monocytogenes with human serum in optimal conditions (20% Mg2+EGTA [ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid]-chelated serum) consumed (31.3 +/- 3.9)% of C3 hemolytic activity and led to similar amounts of C3 deposition among the 27 strains tested, except for a rough mutant and the penicillin-induced L forms of strain EGD, which bound reduced amounts of C3. The same results were obtained with strains belonging to related species (L. innocua, L. seeligeri, L. welshimeri, and L. ivanovii). Direct evidence is provided that L. monocytogenes induces the deposition of C3b and its cleavage products iC3b and C3d through ester and amide linkages, as demonstrated by the analysis of the released products of radiolabelled purified C3 after treatment with hydroxylamine. Our results clearly demonstrate that L. monocytogenes activates the alternative pathway of human complement, suggesting that bacteria in the blood or in tissues of infected patients are opsonized and targeted to C3 receptor-bearing cells such as macrophages.

This article has been cited by other articles:

• Reglier-Poupet, H., Pellegrini, E., Charbit, A., Berche, P. (2003). Identification of LpeA, a PsaA-Like Membrane Protein That Promotes Cell Entry by Listeria monocytogenes. Infect. Immun. 71: 474-482 [Abstract] [Full Text]  
• Vazquez-Boland, J. A., Kuhn, M., Berche, P., Chakraborty, T., Dominguez-Bernal, G., Goebel, W., Gonzalez-Zorn, B., Wehland, J., Kreft, J. (2001). Listeria Pathogenesis and Molecular Virulence Determinants. Clin. Microbiol. Rev. 14: 584-640 [Abstract] [Full Text]  
• Kahler, C. M., Martin, L. E., Shih, G. C., Rahman, M. M., Carlson, R. W., Stephens, D. S. (1998). The (alpha 2right-arrow8)-Linked Polysialic Acid Capsule and Lipooligosaccharide Structure Both Contribute to the Ability of Serogroup B Neisseria meningitidis To Resist the Bactericidal Activity of Normal Human Serum. Infect. Immun. 66: 5939-5947 [Abstract] [Full Text]  
• Wagner, E., Platt, J. L., Frank2, M. M. (1998). High Dose Intravenous Immunoglobulin Does Not Affect Complement-Bacteria Interactions. J. Immunol. 160: 1936-1943 [Abstract] [Full Text]  
• Maganti, S., Pierce, M. M., Hoffmaster, A., Rodgers, F. G. (1998). The Role of Sialic Acid in Opsonin-Dependent and Opsonin-Independent Adhesion of Listeria monocytogenes to Murine Peritoneal Macrophages. Infect. Immun. 66: 620-626 [Abstract] [Full Text]